Laman UtamaNTRA • NASDAQ
add
Natera Inc
Tutup sebelumnya
$236.49
Julat hari
$236.53 - $241.28
Julat tahun
$125.38 - $241.28
Permodalan pasaran
33.02B USD
Bilangan Purata
1.59J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Hasil | 592.18J | 34.66% |
Perbelanjaan pengendalian | 481.96J | 54.93% |
Pendapatan bersih | -87.54J | -177.11% |
Margin untung bersih | -14.78 | -105.85% |
Pendapatan bagi setiap syer | -0.64 | -146.15% |
EBITDA | -87.28J | -180.31% |
Kadar cukai berkesan | -0.24% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.04B | 13.02% |
Jumlah aset | 1.82B | 14.49% |
Jumlah liabiliti | 569.29J | -20.09% |
Jumlah ekuiti | 1.25B | — |
Syer tertunggak | 138.01J | — |
Harga kepada buku | 25.99 | — |
Pulangan pada aset | -13.63% | — |
Pulangan pada modal | -16.86% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -87.54J | -177.11% |
Tunai daripada operasi | 59.39J | 14.68% |
Tunai daripada pelaburan | -19.90J | -146.79% |
Tunai daripada pembiayaan | 1.94J | 12.50% |
Perubahan bersih dalam tunai | 41.42J | -56.88% |
Aliran tunai bebas | 71.33J | 77.49% |
Perihal
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Diasaskan
1 Jan 2004
Ibu pejabat
Tapak web
Pekerja
4,429
